Related Experiment Videos
An overview of novel therapies for Parkinson's disease
1Department of Neurology, Columbia University College of Physicians & Surgeons, New York, New York 10027, USA.
Experimental Neurology
|March 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Alpha galactosidase A activity in Parkinson's disease.
Neurobiology of disease·2018
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.
Movement disorders : official journal of the Movement Disorder Society·2017
Inpatient treatment for functional neurologic disorders.
Handbook of clinical neurology·2016
Increased Rate of Sporadic and Recurrent Rare Genic Copy Number Variants in Parkinson's Disease Among Ashkenazi Jews.
Molecular genetics & genomic medicine·2013
STING-GDF15-STAT3 signaling contributes to neuroinflammation after intracerebral hemorrhage.
Experimental neurology·2026
Ultra-slow release of hydrophilic drugs via multilamellar-multivesicular liposomes formed by unsaturated phospholipids.
Nature biomedical engineering·2026
Modelling the tail-phase pharmacokinetics of long-acting cabotegravir and rilpivirine from early pregnancy to postpartum at steady state.
Journal of pharmacokinetics and pharmacodynamics·2026
The Delivery Strategies for PROTAC.
Handbook of experimental pharmacology·2026
The Impact of Systemic Redistribution on Cutaneous Pharmacokinetic-Based Bioequivalence: An In vivo Dermal Open Flow Microperfusion Study for Lidocaine and Prilocaine.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
Drug repurposing identifies candidate uterus-selective tocolytics for preterm labor.
Science translational medicine·2026
Which drugs will Medicare negotiate next? Predicting selected drugs for Initial Price Applicability Year 2029.
Journal of managed care & specialty pharmacy·2026